Press release
Soaring Demand Set to Propel Companion Animal Arthritis Market to $6.04 Billion by 2029
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.What Is the Expected CAGR for the Companion Animal Arthritis Market Through 2025?
Over the past few years, there has been significant growth in the companion animal arthritis market. The market size is projected to escalate from $3.72 billion in 2024 to $4.08 billion in 2025, signifying a compound annual growth rate (CAGR) of 9.7%. The past growth can be associated with factors such as rising pet ownership, progression in veterinary medicine, and an increase in awareness and education.
What's the Projected Size of the Global Companion Animal Arthritis Market by 2029?
The market for arthritis in companion animals is projected to experience quick expansion in the upcoming years. The market is anticipated to reach $6.04 billion by 2029, with a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the forecast period include an aging pet population, progress in therapeutic solutions, personalized pet nutrition, the application of telemedicine in veterinary care, and the increased humanization of pets. Notable trends over this period include the use of biologicals in veterinary medicine, digital healthcare solutions, nutraceuticals and functional foods, collaborations and strategic partnerships, the influence of pet insurance, consumer preference for natural and holistic therapies, and data-oriented veterinary care.
View the full report here:
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report
Top Growth Drivers in the Companion Animal Arthritis Industry: What's Accelerating the Market?
The growth of the companion animal arthritis market is likely to be driven by the increasing trend of adopting pets. Pet ownership has been known to alleviate stress, anxiety, depression, among other issues. It entails bringing a previously owned dog, cat, or other unconventional pets that were surrendered to shelters or rescue centres, as opposed to acquiring one from pet stores, breeders, or other individuals. As these pets advance in age, they become more susceptible to arthritis. For instance, The American Pet Products Association, a non-profit industry association based in the U.S., revealed in a survey that nearly half of British households with pets added at least one new animal during the country's lockdown. Additionally, around 11.3 million Americans welcomed new pets during the pandemic. Furthermore, the survey found that 16% of Generation Z respondents and 13% of millennials took in a new pet amidst the pandemic. Hence, the escalating trend of pet adoption has a significant bearing on the expansion of the companion animal arthritis market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp
What Trends Will Shape the Companion Animal Arthritis Market Through 2029 and Beyond?
Leading corporations in the companion animal arthritis industry are progressively prioritizing technology-based advancements like sophisticated therapeutic products and supplements to provide pets with effective pain mitigation and enhanced joint health, promising an improved quality of life for older and arthritis-impacted creatures. Bonqat, a newly introduced medication for cats, is instrumental in reducing anxiety during stressful events, such as voyages or vet visits, without inducing drowsiness. The objective of the product is to tranquilize cats, simplifying these stressful occasions for both them and their caretakers. For example, Zoetis Inc., a U.S.A.-based corporation specializing in the production of medicines and vaccines for pets and livestock, introduced Bonqat (pregabalin oral solution) in April 2024 to alleviate felines from acute anxiety and fear linked with transportation and visits to the vet, which could hinder routine care. Pet owners can either mix the oral solution with food or directly feed it to the cats, simplifying its administration. The recommended dose is minuscule (0.1 mL/kg) and the majority of cat owners have reported easy administration.
What Are the Main Segments in the Companion Animal Arthritis Market?
The companion animal arthritis market covered in this report is segmented -
1) By Type: Dogs, Cats, Other Types
2) By Indication: Osteoarthritis, Other Arthritis
3) By Treatment: Medication, Supplements, Other Treatments
4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels
Subsegments:
1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs
2) By Cats: Domestic Cats, Senior Cats
3) By Other Types: Rabbits, Ferrets, Other Small Mammals
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp
Which Top Companies are Driving Growth in the Companion Animal Arthritis Market?
Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill's Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.
Which Regions Will Dominate the Companion Animal Arthritis Market Through 2029?
North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7772
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Soaring Demand Set to Propel Companion Animal Arthritis Market to $6.04 Billion by 2029 here
News-ID: 4076944 • Views: …
More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…

Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…

Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…

Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled…
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are the…
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,…
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report…